• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证 2021 年 IDF-DAR 禁食斋月风险评估工具在巴林王国初级保健机构就诊的糖尿病患者中的应用:DAR-BAH 研究。

Verification of 2021 IDF-DAR risk assessment tool for fasting Ramadan in patients with diabetes attending primary health care in The Kingdom of Bahrain: The DAR-BAH study.

机构信息

Consultant Family Physician, Diabetologist, Clinical Educator in Department of Medicine, RCSI Medical University of Bahrain, The Kingdom of Bahrain.

Consultant Family Physician, Diabetologist, Primary Health Care, The Kingdom of Bahrain.

出版信息

Diabetes Res Clin Pract. 2024 May;211:111661. doi: 10.1016/j.diabres.2024.111661. Epub 2024 Apr 10.

DOI:10.1016/j.diabres.2024.111661
PMID:38604445
Abstract

BACKGROUND

There is a high prevalence of diabetes mellitus among Muslim adult patients. Those Muslims are required to fast the holy month of Ramadan. However, the Islam religion exempted some people with medical issues. It was not clear if all the patients with diabetes were considered medically unfit to fast Ramadan. Therefore, IDF-DAR group created a new risk calculator to categorize the patients with diabetes to advise with or against fasting accordingly.

OBJECTIVE

This study is validating the IDF-DAR tool in assessing the accuracy of IDF-DAR risk calculator tool on adult patients with diabetes visiting primary health care in the Kingdom of Bahrain. The study will facilitate the health care professionals' decision to exempt the patients from fasting.

METHODS

It is a prospective, randomized study for Ramadan 1444/2023 to assess the new IDF-DAR risk score tool that predicts the complications and the negative outcome of fasting during Ramadan. It included pre- and post-Ramadan questionnaires. 757 patients were selected randomly from the patients list of the central diabetes clinics in primary health care for pre-Ramadan risk assessment scoring. Post-Ramadan a phone a questionnaire was done to evaluate the ability of fasting and the occurrence of adverse events.

RESULTS

Out of the 757 participants, 611 were included in the study. The mean age of the studied population was 59.8 years and 52.8 % of them were female. 630 (95.3 %) had type 2 diabetes. According to the new IDF-DAR risk calculator, 184 (27.8 %) were categorized as low risk (≤3 score), 252 (38.1 %) as moderate risk (3-6 score), and 225 (34 %) as high risk (>6 score). The percentage of patients completed their 30 days fasting successfully without reporting adverse events in the low, moderate, and high-risk groups were 92.4 %, 89.3 %, 74.7 % respectively. There was significant increased risk in breaking the fast between the low-risk group and high-risk group with a p-value of <0.001. Similarly, there was significant increased risk in breaking the fast between the moderate-risk group and high-risk group with p-value of <0.001. The main reason of breaking the fast was hypoglycemic attacks. The leading factors that play a significant role in increasing the risk of adverse events during fasting Ramadan were type 1 diabetes mellitus, the presence of previous hypoglycemia attacks, the presence of renal impairment, and negative previous Ramadan experience.

CONCLUSION

The new IDF-DAR risk calculator is a good tool to predict both the ability to fast Ramadan and the probability of experiencing adverse events (mainly hypoglycemia) in people with diabetes mellitus in Kingdom of Bahrain.

摘要

背景

穆斯林成年患者中糖尿病的患病率很高。这些穆斯林被要求在斋月禁食。然而,伊斯兰教豁免了一些有医疗问题的人。目前尚不清楚所有糖尿病患者是否被认为不适宜在斋月禁食。因此,IDF-DAR 小组创建了一个新的风险计算器,对糖尿病患者进行分类,以便据此建议或反对禁食。

目的

本研究旨在验证 IDF-DAR 工具在评估巴林王国初级保健机构就诊的成年糖尿病患者使用 IDF-DAR 风险计算器的准确性。该研究将有助于医疗保健专业人员决定豁免患者禁食。

方法

这是一项针对 1444/2023 年斋月的前瞻性、随机研究,旨在评估新的 IDF-DAR 风险评分工具,该工具可预测糖尿病患者在斋月期间禁食的并发症和不良后果。它包括斋月前和斋月后的问卷调查。从初级保健中心的中央糖尿病诊所的患者名单中随机选择 757 名患者进行斋月前风险评估评分。斋月后,通过电话问卷评估禁食能力和不良事件的发生情况。

结果

在 757 名参与者中,有 611 名被纳入研究。研究人群的平均年龄为 59.8 岁,其中 52.8%为女性。630 名(95.3%)患有 2 型糖尿病。根据新的 IDF-DAR 风险计算器,184 名(27.8%)被归类为低风险(≤3 分),252 名(38.1%)为中风险(3-6 分),225 名(34%)为高风险(>6 分)。在低、中、高风险组中,成功完成 30 天禁食且无不良事件报告的患者比例分别为 92.4%、89.3%和 74.7%。低风险组和高风险组之间的禁食中断风险显著增加,p 值<0.001。同样,中风险组和高风险组之间的禁食中断风险也显著增加,p 值<0.001。禁食中断的主要原因是低血糖发作。在斋月期间发生不良事件(主要是低血糖)的风险增加的主要因素是 1 型糖尿病、既往低血糖发作、肾功能损害和负面的既往斋月经历。

结论

新的 IDF-DAR 风险计算器是一种很好的工具,可以预测巴林王国糖尿病患者在斋月期间禁食的能力和发生不良事件(主要是低血糖)的概率。

相似文献

1
Verification of 2021 IDF-DAR risk assessment tool for fasting Ramadan in patients with diabetes attending primary health care in The Kingdom of Bahrain: The DAR-BAH study.验证 2021 年 IDF-DAR 禁食斋月风险评估工具在巴林王国初级保健机构就诊的糖尿病患者中的应用:DAR-BAH 研究。
Diabetes Res Clin Pract. 2024 May;211:111661. doi: 10.1016/j.diabres.2024.111661. Epub 2024 Apr 10.
2
Validation of the new IDF-DAR risk assessment tool for Ramadan fasting in patients with diabetes.验证新的 IDF-DAR 糖尿病患者开斋节斋戒风险评估工具。
Diabetes Metab Syndr. 2023 Apr;17(4):102754. doi: 10.1016/j.dsx.2023.102754. Epub 2023 Mar 22.
3
Validity of the International Diabetes Federation risk stratification score of Ramadan fasting in individuals with diabetes mellitus.国际糖尿病联合会的糖尿病患者斋月禁食风险分层评分的有效性。
Saudi Med J. 2024 Jan;45(1):86-92. doi: 10.15537/smj.2024.45.1.2023060.
4
Risk stratification using the 2021 IDF-DAR risk calculator and fasting experience of Bangladeshi subjects with type 2 diabetes in Ramadan: The DAR-BAN study.使用2021年国际糖尿病联盟-糖尿病缓解评估风险计算器对斋月期间孟加拉国2型糖尿病患者进行风险分层及禁食体验:DAR-BAN研究
J Clin Transl Endocrinol. 2023 Feb 16;31:100315. doi: 10.1016/j.jcte.2023.100315. eCollection 2023 Mar.
5
Risk factors associated with fasting during Ramadan among individuals with diabetes according to IDF-DAR risk score in Atbara city, Sudan: Cross-sectional hospital-based study.根据 IDF-DAR 风险评分,在苏丹阿特巴拉市,糖尿病患者在斋月期间禁食的相关风险因素:基于医院的横断面研究。
Diabetes Metab Syndr. 2023 Mar;17(3):102743. doi: 10.1016/j.dsx.2023.102743. Epub 2023 Mar 12.
6
Risk Stratification, Intention to Fast, and Outcomes of Fasting During Ramadan in People With Diabetes Presenting to a Tertiary Care Hospital.在一家三级护理医院就诊的糖尿病患者在斋月期间进行斋戒的风险分层、禁食意愿和结局。
Endocr Pract. 2024 Oct;30(10):951-956. doi: 10.1016/j.eprac.2024.06.013. Epub 2024 Jul 4.
7
Evidence-based risk factors for major complications during Ramadan fasting in people with diabetes grouped under IDF-DAR risk categories.基于证据的糖尿病患者在斋月禁食期间发生主要并发症的风险因素,按 IDF-DAR 风险类别分组。
Diabetes Res Clin Pract. 2022 Mar;185:109234. doi: 10.1016/j.diabres.2022.109234. Epub 2022 Feb 4.
8
Ramadan fasting in a sample Algerian population with diabetes.在有糖尿病的阿尔及利亚人群中进行斋月禁食。
Diabetes Res Clin Pract. 2022 Jun;188:109901. doi: 10.1016/j.diabres.2022.109901. Epub 2022 May 2.
9
Patterns of Diabetes Care Among People with Type 1 Diabetes During Ramadan: An International Prospective Study (DAR-MENA T1DM).1 型糖尿病患者在斋月期间的糖尿病护理模式:一项国际前瞻性研究(DAR-MENA T1DM)。
Adv Ther. 2020 Apr;37(4):1550-1563. doi: 10.1007/s12325-020-01267-4. Epub 2020 Mar 6.
10
Diabetes and Ramadan: Practical guidelines 2021.糖尿病与开斋节:2021 年实用指南。
Diabetes Res Clin Pract. 2022 Mar;185:109185. doi: 10.1016/j.diabres.2021.109185. Epub 2022 Jan 8.

引用本文的文献

1
Validation of the IDF-DAR risk assessment tool for Ramadan fasting in patients with diabetes in primary care.基层医疗中糖尿病患者斋月禁食的IDF-DAR风险评估工具的验证
Front Clin Diabetes Healthc. 2025 Mar 21;6:1426120. doi: 10.3389/fcdhc.2025.1426120. eCollection 2025.
2
Validity of the New International Diabetes Federation-Diabetes and Ramadan (IDF-DAR) Risk Stratification Score and Fasting Experience of Saudi Patients With Diabetes During Ramadan: Insights From a Cross-Sectional Study.新国际糖尿病联盟 - 糖尿病与斋月(IDF - DAR)风险分层评分的有效性及沙特糖尿病患者斋月期间的禁食体验:一项横断面研究的见解
Cureus. 2025 Feb 20;17(2):e79351. doi: 10.7759/cureus.79351. eCollection 2025 Feb.
3
Implications of the Glycemia Risk Index in Assessing Metabolic Control and its Correlation With Therapy-Related Quality of Life During-Ramadan Fasting in Adults With Type 2 Diabetes.
血糖风险指数在评估2型糖尿病成人患者斋月禁食期间代谢控制及其与治疗相关生活质量相关性中的意义
J Diabetes Sci Technol. 2025 Feb 28:19322968251321860. doi: 10.1177/19322968251321860.
4
Personalized risk reduction strategies utilizing the diabetes and ramadan risk calculator: a narrative review.利用糖尿病与斋月风险计算器的个性化风险降低策略:一项叙述性综述
J Diabetes Metab Disord. 2024 Dec 28;24(1):30. doi: 10.1007/s40200-024-01506-3. eCollection 2025 Jun.
5
Ramadan diurnal intermittent fasting in patients with diabetes: assessment of knowledge, practices, risk of complications, and impact of pre-ramadan education.糖尿病患者的斋月日间间歇性禁食:知识、实践、并发症风险评估以及斋月前教育的影响
J Diabetes Metab Disord. 2024 Dec 16;24(1):9. doi: 10.1007/s40200-024-01529-w. eCollection 2025 Jun.
6
5. Facilitating Positive Health Behaviors and Well-being to Improve Health Outcomes: Standards of Care in Diabetes-2025.5. 促进积极的健康行为和福祉以改善健康结局:2025年糖尿病照护标准
Diabetes Care. 2025 Jan 1;48(Supplement_1):S86-S127. doi: 10.2337/dc25-S005.
7
Glucometric parameter changes in patients with type 2 diabetes during ramadan fasting: A prospective comparative real-world study.2型糖尿病患者斋月禁食期间的血糖参数变化:一项前瞻性比较现实世界研究。
Metabol Open. 2024 Jul 26;23:100304. doi: 10.1016/j.metop.2024.100304. eCollection 2024 Sep.